| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.8M | -49.5% |
| SG&A Expense | $5.7M | -35.4% |
| Operating Income | -$11.5M | +58.4% |
| Pre-tax Income | -$11.1M | +59.4% |
| Net Income | -$11.1M | +59.4% |
| EPS (Basic) | -$8.48 | -398.8% |
| EPS (Diluted) | -$8.48 | +75.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | -27.6% |
| Current Assets | $5.6M | -32.8% |
| Total Assets | $5.8M | -32.9% |
| Current Liabilities | $731K | -26.8% |
| Total Liabilities | $797K | -30.6% |
| Stockholders' Equity | $5.0M | -33.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | +16.1% |
| Capital Expenditures | $3K | — |
| Investing Cash Flow | -$3K | — |
| Financing Cash Flow | $6.3M | +1712.1% |
| Free Cash Flow | -$8.1M | — |